Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMQ5AJ6)

• Drug Name: Selenium compound 3 Drug Info
• Synonyms: PMID25468267-Compound-30
• Cross-matching ID:
  PubChem CID: 3194
  ChEBI ID: CHEBI:77543
  CAS Number: CAS 60940-34-3
  TTD Drug ID: DMQ5AJ6

Molecule-Related Drug Atlas

Drug(s) Targeting Lysine-specific demethylase 4A (KDM4A)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID25468267-Compound-46	DMSKCEH	N. A.	N. A.	Patented	[1]
N-(2-phenylcyclopropyl) amino acid derivative 1	DMH7T8C	N. A.	N. A.	Patented	[2]
Heteroaryl-cyclopropylamine derivative 4	DMMU01R	N. A.	N. A.	Patented	[2]
PMID27019002-Compound-21b	DMMC31N	N. A.	N. A.	Patented	[2]
Hydroxamate analog 1	DMGATHZ	N. A.	N. A.	Patented	[1]
PMID27019002-Compound-21c	DMWZOKP	N. A.	N. A.	Patented	[2]
Disulfiram analog 1	DMOEFD3	N. A.	N. A.	Patented	[1]
Selenium compound 2	DMLWIJ7	N. A.	N. A.	Patented	[1]
Disulfiram analog 2	DMOMGU5	N. A.	N. A.	Patented	[1]
Selenium compound 1	DM9C5Z8	N. A.	N. A.	Patented	[1]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Lysine-specific demethylase 4A (KDM4A)	TTZHPB8	KDM4A_HUMAN	Inhibitor	[1]

References

• [1] KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44.
• [2] LSD1 inhibitors: a patent review (2010-2015).Expert Opin Ther Pat. 2016 May;26(5):565-80.